Results 71 to 80 of about 8,107 (190)

Intraventricular Cavernoma

, 2018
Intraventricular cavernomas (IVC) are rare entities. We report a case of incidentally detected intraventricular cavernoma (IVC) in frontal horn of the lateral ventricle in which the diagnosis was established by typical magnetic resonance imaging (MRI ...
Kumar Savith, Savith Kumar
core   +1 more source

Mapping the neurovascular landscape in aging and dementia: cerebral small vessel disease markers in a multicenter Latin American cohort

Alzheimer's &Dementia, Volume 22, Issue 5, May 2026.
Abstract INTRODUCTION Cerebral small vessel disease (CSVD) is a key contributor to cognitive impairment and dementia, yet few studies have compared CSVD across dementia variants, particularly in underrepresented populations. METHODS In a multicenter cross‐sectional study, we analyzed magnetic resonance imaging (MRI) markers of CSVD, including white ...
Florencia Altschuler, Ana Maria Castro‐Laguardia, Verónica Canziani, Daniel Franco O'Byrne, Jessica Hazelton, Joaquín Migeot, Marcelo Maito, Adolfo M. García, Martín A. Bruno, Nahuel Magrath, Andrea Slachevsky, María Isabel Behrens, Nilton Custodio, José Alberto Ávila‐Funes, Diana Matallana, David Aguillón, Hernando Santamaria‐García, Elisa Resende, Leonel Takada, Luis Ignacio Brusco, Jennifer S. Yokoyama, Bruce Miller, Agustín Ibáñez, Vicente Medel, Cecilia Gonzalez Campo   +24 more
wiley   +1 more source

Cerebral cavernoma in a child caused by programmed cell death 10 gene mutation: a case report

Zhongguo Linchuang Yixue
The clinical data and genetic test results of a 7-year-old female child with cerebral cavernoma were retrospectively analyzed. The child was admitted to the hospital due to a one-month headache. Brain MRI showed cerebral cavernoma.
Fuhui LIU, Zongming HAN, Minglei LI, Zufang LÜ   +3 more
doaj   +1 more source

High Levels of Receptor Tyrosine Kinases in CCM3-Deficient Cells Increase Their Susceptibility to Tyrosine Kinase Inhibition

Biomedicines, 2020
Cerebral cavernous malformations (CCMs) are vascular malformations that can be the result of the deficiency of one of the CCM genes. Their only present treatment is surgical removal, which is not always possible, and an alternative pharmacological ...
Miriam Sartages, Ebel Floridia, Mar García-Colomer, Cristina Iglesias, Manuel Macía, Patricia Peñas, Pierre-Olivier Couraud, Ignacio A. Romero, Babette Weksler, Celia M. Pombo, Juan Zalvide   +10 more
doaj   +1 more source

Cavernoma

, 2009
Dos imágenes de un cavernoma en una paciente de 33 años.Two pictures of a cavernoma in a 33-year-old female ...
Iglesias Rozas, José Rafael, 1942-
core  

Parkinsonism caused by cavernoma located in basal ganglion

, 2005
Deep-seated cavernoma or cavernous angioma is a very rare clinical entity, as is basal ganglia cavernoma presenting with Parkinsonism. The authors demonstrate a 56-year-old man with a cavernoma located in basal ganglion, who subsequently developed ...
Alver, I, Tanriverdi, T, Ertan, S, Benbir, G, Uzan, M   +4 more
core   +1 more source

Freedon study: Real‐life outcomes of cenobamate in different lines of treatment

Epilepsia, Volume 67, Issue 5, Page 2177-2189, May 2026.
Abstract Objectives Cenobamate is an antiseizure medication (ASM) with proven effectiveness in individuals with highly refractory epilepsy. This study investigated the effectiveness and tolerability of cenobamate in different treatment lines and a less refractory setting. Methods This was a multicenter, retrospective, observational study.
Vicente Villanueva, José María Serratosa, Alejandro Fernández‐Cabrera, Manuel Toledo, Beatriz González‐Giráldez, José C. Estevez, Juan Jesús Rodríguez Uranga, Maria Machio Castelló, Maria Dolores Castro‐Vilanova, Juan José Poza, Xiana Rodríguez‐Osorio, Kevin G. Hampel, Elena Fonseca, Francisco Javier López‐González, Mercedes Garcés, Laura Abraira, Jordi Ciurans, Daniel Campos‐Fernández, Estevo Santamarina, Juan María Sanchez‐Caro, Lucas Iacampo, Julia Renau, Miguel Ángel García‐Quesada, Carla Anciones, María Isabel Chamorro, Iratxe Maestro, Pablo Cabezudo, Raquel Calle, Jesús Macarron, Beatriz Cabezas, María Carrasco, María López, Marta Marín, Rosa Querol, Belén Baena, Vanessa García‐Morales, Samuel López‐Maza, Álvaro Juiz, Blanca Mercedes‐Alvarez, Carla Amarante, Ana del Villar, Ascensión Castillo, Marta Rubio‐Roy, Javier Martinez‐Poles, Asier Gómez‐Ibáñez, Beatriz Parejo‐Carbonell, Anabelén Martínez Garcia, Ignacio Carrera, Pablo Iriarte, Fátima Romero‐Aguilera, on behalf of the Pharmacological Therapy Working group of the Spanish Epilepsy Society and Freedon Group   +50 more
wiley   +1 more source

Trends in the incidence of newly diagnosed cerebral cavernous malformations in Finland: a population-based retrospective cohort studyResearch in context

The Lancet Regional Health. Europe
Summary: Background: The few previous studies that have estimated the incidence of cerebral cavernous malformations (cavernomas) have reported incidence rates of 0.2–1.9/100,000 for diagnosed cavernomas.
Aleksi Halmela, Emilia Saari, Jani Raitanen, Timo Koivisto, Anssi Auvinen, Juhana Frösen   +5 more
doaj   +1 more source

Cavernoma de la órbita

, 2009
Cuatro imágenes de un cavernoma de la órbita.Four pictures of a cavernoma in the ...
Iglesias Rozas, José Rafael, 1942-
core  

Comparison of portal vein (PV) occlusion between patients with and without cavernoma.

, 2014
PV occlusion in patients with cavernoma was significantly higher than those without cavernoma ...
Jianjun Luo (160162), Shijing Qiu (525218), Jingqin Ma (659927), Jianhua Wang (159545), Zhiping Yan (329059), Qingxin Liu (659928)   +5 more
core   +1 more source